Tumor growth suppression using a combination of taxol-based therapy and GSK3 inhibition in non-small cell lung cancer.

PLoS One · 2019 · PMC6457575 · PMID 30969984

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

By contrast, the combination treatment promoted a highly significant increase in the percentage of misaligned chromosomal DNA in a synergistic manner relative to the DMSO control or cells treated with CHIR99021 or paclitaxel on their own ( p = 0.01, 0.04 and 0.02 versus each of DMSO, CHIR99021 or paclitaxel alone).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.